Literature DB >> 2538812

Nerve growth factor stimulates the hydrolysis of glycosylphosphatidylinositol in PC-12 cells: a mechanism of protein kinase C regulation.

B L Chan1, M V Chao, A R Saltiel.   

Abstract

Treatment of PC-12 pheochromocytoma cells with nerve growth factor (NGF) results in the differentiation of these cells into a sympathetic neuron-like phenotype. Although the initial intracellular signals elicited by NGF remain unknown, some of the cellular effects of NGF are similar to those of other growth factors, such as insulin. We have investigated the involvement of a newly identified inositol-containing glycolipid in signal transduction for the actions of NGF. NGF stimulates the rapid generation of a species of diacylglycerol that is labeled with [3H]myristate but not with [3H]arachidonate. NGF stimulates [3H]myristate- or [32P]phosphate-labeled phosphatidic acid production over the same time course. Although NGF alone has no effect on the turnover of inositol phospholipids, it does stimulate the hydrolysis of glycosylphosphatidylinositol. The NGF-dependent cleavage of this lipid is accompanied by an increase in the accumulation of its polar head group, an inositol phosphate glycan, which is generated within 30-60 sec of NGF treatment. In an unresponsive PC-12 mutant cell line, neither the diacylglycerol nor inositol phosphate glycan response is detected. A possible role for the NGF-stimulated diacylglycerol is suggested by the inhibition of NGF-dependent c-fos induction by staurosporin, a potent inhibitor of protein kinase C. These results suggest that, like insulin, some of the cellular effects of NGF may be mediated by the phospholipase C-catalyzed hydrolysis of glycosylphosphatidylinositol.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2538812      PMCID: PMC286783          DOI: 10.1073/pnas.86.6.1756

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Alterations in the surface properties of cells responsive to nerve growth factor.

Authors:  D Schubert; M LaCorbiere; C Whitlock; W Stallcup
Journal:  Nature       Date:  1978-06-29       Impact factor: 49.962

2.  Post-synaptic PI-effect of nerve growth factor in rat superior cervical ganglia.

Authors:  J Lakshmanan
Journal:  J Neurochem       Date:  1979-05       Impact factor: 5.372

Review 3.  The nerve growth factor: biochemistry, synthesis, and mechanism of action.

Authors:  L A Greene; E M Shooter
Journal:  Annu Rev Neurosci       Date:  1980       Impact factor: 12.449

4.  Clonal variants of PC12 pheochromocytoma cells with altered response to nerve growth factor.

Authors:  M A Bothwell; A L Schechter; K M Vaughn
Journal:  Cell       Date:  1980-10       Impact factor: 41.582

5.  Ca2+ transmembrane fluxes and nerve growth factor action on a clonal cell line of rat phaeochromocytoma.

Authors:  G Landreth; P Cohen; E M Shooter
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

6.  Nerve growth factor mediates phosphorylation of specific proteins.

Authors:  S Halegoua; J Patrick
Journal:  Cell       Date:  1980-11       Impact factor: 41.582

7.  Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose.

Authors:  L Ellis; E Clauser; D O Morgan; M Edery; R A Roth; W J Rutter
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

8.  Increased phosphorylation of specific nuclear proteins in superior cervical ganglia and PC12 cells in response to nerve growth factor.

Authors:  M W Yu; N W Tolson; G Guroff
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

9.  Selective induction by nerve growth factor of tyrosine hydroxylase and dopamine- -hydroxylase in the rat superior cervical ganglia.

Authors:  H Thoenen; P U Angeletti; R Levi-Montalcini; R Kettler
Journal:  Proc Natl Acad Sci U S A       Date:  1971-07       Impact factor: 11.205

10.  Differential and synergistic actions of nerve growth factor and cyclic AMP in PC12 cells.

Authors:  P W Gunning; G E Landreth; M A Bothwell; E M Shooter
Journal:  J Cell Biol       Date:  1981-05       Impact factor: 10.539

View more
  18 in total

1.  Compartmentalized signaling by GPI-anchored ephrin-A5 requires the Fyn tyrosine kinase to regulate cellular adhesion.

Authors:  A Davy; N W Gale; E W Murray; R A Klinghoffer; P Soriano; C Feuerstein; S M Robbins
Journal:  Genes Dev       Date:  1999-12-01       Impact factor: 11.361

2.  AuBr(3) mediated glycosidations: synthesis of tetrasaccharide motif of the Leishmania donovani lipophosphoglycan.

Authors:  Gopalsamy Sureshkumar; Srinivas Hotha
Journal:  Glycoconj J       Date:  2012-06-03       Impact factor: 2.916

3.  Multi-level regulation of Thy-1 antigen expression in mouse T lymphomas.

Authors:  N J Fasel; N Déglon
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

Review 4.  Fos-jun and the primary genomic response in the nervous system. Possible physiological role and pathophysiological significance.

Authors:  J P Doucet; S P Squinto; N G Bazan
Journal:  Mol Neurobiol       Date:  1990 Spring-Summer       Impact factor: 5.590

Review 5.  Identification of tyrosine kinase Trk as a nerve growth factor receptor.

Authors:  A H Ross
Journal:  Cell Regul       Date:  1991-09

6.  Nerve growth factor stimulates protein tyrosine phosphorylation in PC-12 pheochromocytoma cells.

Authors:  T Miyasaka; D W Sternberg; J Miyasaka; P Sherline; A R Saltiel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

7.  Intracellular cleavage of glycosylphosphatidylinositol by phospholipase D induces activation of protein kinase Calpha.

Authors:  H Tsujioka; N Takami; Y Misumi; Y Ikehara
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

8.  Nerve growth factor induces the association of a 130-Kd phosphoprotein with its receptor in PC-12 pheochromocytoma cells.

Authors:  M Ohmichi; S J Decker; A R Saltiel
Journal:  Cell Regul       Date:  1991-09

Review 9.  The role of glycosyl-phosphoinositides in hormone action.

Authors:  A R Saltiel
Journal:  J Bioenerg Biomembr       Date:  1991-02       Impact factor: 2.945

Review 10.  Therapy with central active catechol-O-methyltransferase (COMT)-inhibitors: is addition of monoamine oxidase (MAO)-inhibitors necessary to slow progress of neurodegenerative disorders?

Authors:  T Müller; W Kuhn; H Przuntek
Journal:  J Neural Transm Gen Sect       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.